C-Reactive Protein Level Predicts Survival Outcomes in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation Therapy.

Kim, Woo Ram; Han, Yoon Dae; Min, Byung Soh

Kim, Woo Ram; Han, Yoon Dae; Min, Byung Soh.

Affiliation

Kim WR; Department of Surgery, CHA Bundang Medical Center, CHA University, Seongnam, Gyeonggi, Korea.
Han YD; Department of Surgery, Yonsei University College of Medicine, Yonsei University Health System, Seoul, Korea.
Min BS; Department of Surgery, Yonsei University College of Medicine, Yonsei University Health System, Seoul, Korea.

Ann Surg Oncol ; 25(13): 3898-3905, 2018 Dec.

Article in En | MEDLINE | ID: mdl-30288654

Subject(s)

Adenocarcinoma/blood; Adenocarcinoma/therapy; C-Reactive Protein/metabolism; Rectal Neoplasms/blood; Rectal Neoplasms/therapy; Adenocarcinoma/secondary; Aged; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Body Mass Index; Capecitabine/administration & dosage; Chemoradiotherapy, Adjuvant; Digestive System Surgical Procedures; Disease-Free Survival; Female; Fluorouracil/administration & dosage; Follow-Up Studies; Humans; Leucovorin/administration & dosage; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Preoperative Period; Radiotherapy Dosage; Rectal Neoplasms/pathology; Survival Rate

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rectal Neoplasms / C-Reactive Protein / Adenocarcinoma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Surg Oncol Journal subject: NEOPLASIAS Year: 2018 Type: Article

Fulltext

XML

PubMed Links

Search on Google